A new clinical trial has found that a daily combination of vitamins and minerals may help reduce irritability in teenagers, offering a potentially simple and safe treatment option for young people struggling with mood dysregulation.
The study, titled 'Efficacy and Safety of Micronutrient Treatment for Irritability in Teenagers: 8-Week Double-Blinded Randomized Placebo-Controlled Trial (BEAM)', examined whether a broad-spectrum micronutrient supplement could help adolescents with moderate-to-severe irritability.
Researchers note that irritability is a major mental-health concern among young people. As the study explains, “Irritability is a central component of psychological distress in young people and is considered a transdiagnostic dimension.” It is typically marked by “excessive reactivity to negative emotional stimuli with temper outbursts and irritable mood components.”
A widespread mental health concern
The researchers point out that “because of its high prevalence and persistence, as well as developmental comorbidities, irritability in childhood is one of the most psychosocially impairing and costly mental health symptom constellations.”
For your daily dose of medical news and updates, visit: HEALTH
The trial involved 132 teenagers aged 12 to 17 who were not taking psychiatric medication but had significant irritability symptoms. Participants were randomly assigned to receive either a micronutrient supplement or an active placebo for eight weeks.
The study monitored participants remotely through weekly questionnaires completed by both parents and teenagers, along with monthly online sessions with a registered psychologist.
Micronutrient supplements show measurable improvements
The main goal was to see whether micronutrients could improve irritability and emotional regulation. According to the researchers, the results suggest some benefits.
The trial “provides preliminary evidence that micronutrients may be an effective and safe treatment for teen irritability.” Participants who took micronutrients showed measurable improvement in several key assessments compared with those taking a placebo. Statistical models showed “significant main effects of treatment on the CGI-I and EDI,” which are commonly used clinical measures of improvement and emotional reactivity.
However, not all measures showed improvement. The researchers reported that there was no statistically significant difference between the two groups on another clinical scale known as CL-ARI-Total.
Even so, several secondary outcomes suggested additional benefits. The study found improvements in the overall severity of symptoms, conduct problems, prosocial behaviour, and suicidal thoughts among teenagers taking micronutrients.
The authors write that “secondary outcomes highlighted significant benefits of micronutrients over placebo on CGI-Severity, parent-reported conduct symptoms and prosocial behavior, and teen-reported suicidal ideation.”
Another encouraging finding was the speed of improvement in several areas. According to the study, “micronutrients also led to faster improvement in clinician-rated irritability, parent-rated dysphoria, and teen-rated quality of life, stress, and prosocial behaviors.”
The benefits were particularly striking for teenagers diagnosed with disruptive mood dysregulation disorder (DMDD), a condition characterized by chronic irritability and severe temper outbursts.
For this subgroup, the effects of micronutrients were dramatic. The study reports that “64.3% of DMDD participants were responders on micronutrients compared with 12.5% on placebo.”
Effect sizes in this group were also very large, ranging from 1.06 to 1.44, suggesting a substantial improvement compared with the placebo group.
Researchers also observed that socio-economic status influenced outcomes, with teens from lower-income families more likely to respond positively to micronutrient treatment.
The study’s authors say the findings are important because current treatments for chronic irritability in children and adolescents are often limited.
They note that the use of psychiatric medications has increased even though “poor efficacy data, significant side effects, lack of placebo-controlled trials, and lack of standardised guidelines” remain concerns.
Psychotherapy, meanwhile, can be difficult to access. As the researchers write, therapy also faces “challenges with access and long waiting lists.”
Given these barriers, the authors say there is an urgent need for simpler and more scalable interventions.
They argue that improving nutrition may play an important role in emotional health during adolescence. Previous research has linked poor diet to mental-health problems, and the study notes that “improving adolescent nutrition may help regulate emotions and behavior.”
Taking supplements may also be easier for teenagers than changing eating habits. The researchers explain that “supplementation with micronutrients could be advantageous because of the relative simplicity of the intervention (pill swallowing) compared to diet change.”
In terms of safety, the study found relatively few side effects. The only significant difference between the two groups was that diarrhea occurred more frequently among participants taking micronutrients, affecting about 20.9%, compared with 6.2% in the placebo group.
Researchers call for larger studies
A small number of participants also reported difficulty swallowing the capsules, though the researchers say “a minority of participants (<10%) found swallowing pills a challenge.”
Despite the promising results, the researchers emphasize that the findings are still preliminary and need replication in larger studies.
Still, they believe the approach could have major implications if future research confirms the results.
As the authors conclude, the trial “provides preliminary evidence that micronutrients may be an effective and safe treatment for teen irritability, with a reassuring reduction in suicidal ideation and, if findings are replicated, may transform outcomes for teens.”
This story is done in collaboration with First Check, which is the health journalism vertical of DataLEADS.
